Minerva Neurosciences (NERV) Misses Q2 EPS by 12c

Minerva Neurosciences (NASDAQ: NERV) reported Q2 EPS of ($1.09), $0.12 worse than the analyst estimate of ($0.97).

For earnings history and earnings-related data on Minerva Neurosciences (NERV) click here.

You May Also Be Interested In

• Gulfport Energy and Mobility Global to join S&P SmallCap 600
• TEN Holdings prices $7.5 million common stock offering at $1 per share
• AES stockholders approve $10.7 billion takeover by GIP and EQT